NCT00235222View on ClinicalTrials.gov

Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

PHASE4UnknownINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

March 31, 2006

Conditions

HIV

Interventions

DRUG

stavudine

Trial Locations (1)

75013

Service de Maladies Infectieuses Hôpital Pitié-Salpêtrière, Paris

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Groupe Hospitalier Pitie-Salpetriere

OTHER